Skip to main content
Sign In
 

2019 Preliminary Program


 "Altered Metabolism in PAECs and the RV”

Serpil C. Erzurum, M.D.

Cleveland, Ohio​

1

 ​"Immunologic and Metabolic Alterations in a Nonhuman Primate Model of Pulmonary Hypertension"

Karen A. Norris, Ph.D.

Athens, Georgia​​

2

 “Crosstalk Between Autophagic Metabolism and Angiocrine Signaling in PAH”

Augustine M.K. Choi, M.D.

New York, New York​

3

 "Metabolism as a Therapeutic Target in Pulmonary Hypertension and the RV”

Anna R. Hemnes, M.D.

Nashville, Tennessee​​​

4

 "Hypoxia Signaling in Cancer"

M. Celeste Simon, Ph.D.

Philadelphia, Pennsylvania

5

 "Hypoxia Signaling in Pulmonary Hypertension”

Larissa A. Shimoda, M.S., Ph.D.

Baltimore, Maryland

6

 "Angiogenesis Revisited: Role and (Therapeutic) Implications of Endothelial Metabolism”

Peter Carmeliet, M.D., Ph.D.​

Leuven, Belgium​​

7

 “The Pivotal Role of BMPR2 in Preventing Pulmonary Hypertension”

Marlene Rabinovitch, M.D.​

Stanford, California​​

8

 "Transcription Factor Regulation of Pulmonary Hypertension and Cancer”

Soni S. Pullamsetti, Ph.D.

Bad Neuheim, Germany

9

 “Novel Treatment Targets in Pulmonary Hypertension”

Steven M. Kawut, M.D., M.S.​

Philadelphia, Pennsylvania​

10

 "Bridging Genes to Phenotype in Pulmonary Hypertension”

Mark W. Geraci, M.D.

Indianapolis, Indiana ​​​​

12

 “Four Decades of Personalized Medicine in Breast Cancer: Lessons for Drug Development in Pulmonary Hypertension”

Tatiana M. Prowell, M.D. 

Silver Spring, Maryland​​
​​11

 CONFERENCE SUMMARY

Mark T. Gladwin, M.D.

Pittsburgh, Pennsylvania​

14